Letter: Does Serum HBV RNA Add Incremental Value for Hepatocellular Carcinoma Risk Stratification Beyond Established Predictors?
Alimentary Pharmacology & Therapeutics · 2026-06 · 63 (12) · 1699-1700
DOI: 10.1111/apt.70708 ↗At a glance
Leserbrief in Alimentary Pharmacology & Therapeutics, published online on 2026-05-04. Written by Yuanyan Sun and 1 co-authors. Institution: Department of Clinical Laboratory, Shandong Provincial Third Hospital, Shandong University, Jinan City, Shandong Province, China. Cited 1 times so far (Crossref); 5 references.
Abstract (original language)
Niciun rezumat disponibil.
Authors and institutions
- Department of Clinical Laboratory, Shandong Provincial Third Hospital, Shandong University, Jinan City, Shandong Province, China.
ORCID profiles: Yonggang Dai
Cite
APA
Sun, Y., & Dai, Y. (2026). Letter: Does Serum HBV RNA Add Incremental Value for Hepatocellular Carcinoma Risk Stratification Beyond Established Predictors?. Alimentary Pharmacology & Therapeutics, 63(12), 1699-1700. https://doi.org/10.1111/apt.70708
Vancouver
Sun Y, Dai Y. Letter: Does Serum HBV RNA Add Incremental Value for Hepatocellular Carcinoma Risk Stratification Beyond Established Predictors?. Alimentary Pharmacology & Therapeutics. 2026;63(12):1699-1700. doi:10.1111/apt.70708
BibTeX
@article{Sun2026,
author = {Sun, Yuanyan and Dai, Yonggang},
title = {Letter: Does Serum HBV RNA Add Incremental Value for Hepatocellular Carcinoma Risk Stratification Beyond Established Predictors?},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {63},
number = {12},
pages = {1699--1700},
doi = {10.1111/apt.70708}
}
EUVIMED